AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
256.91
-2.45 (-0.94%)
At close: Jul 27, 2026, 4:00 PM EDT
257.82
+0.91 (0.35%)
After-hours: Jul 27, 2026, 7:59 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
47.59B46.60B43.03B
International Revenue
15.23B14.56B13.31B
Revenue (Total)
62.82B61.16B56.33B

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Immunology Revenue
31.43B30.41B26.68B
Neuroscience Revenue
11.36B10.77B9.00B
Oncology Revenue
6.65B6.66B6.56B
Aesthetics Revenue
4.94B4.86B5.18B
Eye Care Revenue
-2.11B2.24B
Other Key Products Revenue
3.92B3.74B3.65B
All Other Revenue
2.91B2.63B3.03B
Revenue (Other)
1.60B--
Revenue (Total)
62.82B61.16B56.33B